These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3759567)

  • 21. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
    Mulcahy RT
    Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the effects of the hyperthermic treatment by N-methylformamide on a human melanoma cell line.
    Arancia G; Meschini S; Matarrese P; Malorni W; Candiloro A; Mattioni M; Santoni G; Zupi G
    Anticancer Res; 1994; 14(3A):905-13. PubMed ID: 8074492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth delay in small EMT6 spheroids induced by cytotoxic drugs and its modification by misonidazole pretreatment under hypoxic conditions.
    Twentyman PR
    Br J Cancer; 1982 Apr; 45(4):565-70. PubMed ID: 7073947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Misonidazole chemosensitization of EMT6 spheroids to melphalan.
    Horsman MR; Wood PJ; Brown JM
    Radiother Oncol; 1989 May; 15(1):103-14. PubMed ID: 2748937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of the hypoxic fraction of a xenografted human colon tumor by differentiation-inducing agents.
    Leith JT
    J Natl Cancer Inst; 1988 May; 80(6):444-7. PubMed ID: 3367384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen dependence for chemosensitization by misonidazole.
    Roizin-Towle L; Hall EJ; Pirro JP
    Br J Cancer; 1986 Dec; 54(6):919-24. PubMed ID: 3801287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased hypoxic toxicity and binding of misonidazole by low glucose concentration.
    Ling LL; Streffer C; Sutherland R
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1231-4. PubMed ID: 3744943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of cytotoxic drugs by misonidazole (MISO) in Lewis lung tumors of different sizes, and mouse bone marrow.
    Spooner D; Peacock JH; Stephens TC
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):643-6. PubMed ID: 7107390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-link formation and chemopotentiation of EMT-6/Ro cells exposed to MISO after CCNU treatment in vitro.
    Mulcahy RT
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1389-92. PubMed ID: 3759561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT; Dembs N
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Misonidazole increases the toxicity of BCNU for hypoxic cells.
    Tannock I; Guttman P
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):663-6. PubMed ID: 7107395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different effects of sequential combinations of N-methylformamide with 5-fluorouracil on human colon carcinoma cells growing in nude mice.
    Arancia G; Leonetti C; Malorni W; Greco C; Formisano G; Marangolo M; Zupi G
    J Cancer Res Clin Oncol; 1991; 117(4):351-8. PubMed ID: 2066356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between misonidazole and hyperthermia in EMT6 spheroids.
    Morgan JE; Bleehen NM
    Br J Cancer; 1981 Dec; 44(6):810-8. PubMed ID: 7326192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the cytotoxicity of 5-thio-D-glucose and misonidazole on hypoxic cells in vitro.
    Song CW; Lee CK; Rhee JG; Levitt SH
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):749-52. PubMed ID: 6809705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytoskeleton-dependent surface blebbing induced by the polar solvent N-methylformamide.
    Malorni W; Meschini S; Arancia G
    Exp Mol Pathol; 1992 Oct; 57(2):85-104. PubMed ID: 1426160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo radiosensitization by 2-nitroimidazoles more electron-affinic than misonidazole.
    Brown DM; Yu NY; Brown JM; Lee WW
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):435-8. PubMed ID: 7107364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversible suppression of c-myc expression in a human colon carcinoma line by the anticancer agent N-methylformamide.
    Chatterjee D; Mendelsohn A; Shank PR; Savarese TM
    Cancer Res; 1989 Jul; 49(14):3910-6. PubMed ID: 2660982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential.
    Mulcahy RT; Dembs NL; Ublacker GA
    Br J Cancer; 1984 Mar; 49(3):307-13. PubMed ID: 6704305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
    Iwakawa M; Tofilon PJ; Arundel C; Milas L
    Cancer Res; 1989 Apr; 49(7):1640-3. PubMed ID: 2924311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misonidazole and MTDQ in combination: cytotoxic and radiosensitizing properties in hypoxic mammalian cells.
    Astor M; Hall EJ
    Br J Cancer; 1979 May; 39(5):510-5. PubMed ID: 486306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.